Risto Kerkelä, MD, PhD (University of Oulu, Finland) "Cardiotoxicity of tyrosine kinase inhibitor cancer therapeutics" will has a presentation.
Monday, 13.10.08 in Heart Institute, Univ. of Pécs, Ifjúság út 13. - Kerkelä R, Grazette L, Yacobi R, et al. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med. 2006;2(8):908-916. - Chu TF, Rupnick MA, Kerkelä R, et al. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet. 2007;370(9604):2011-2019. - Chen MH, Kerkelä R, Force T. Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics. Circulation. 2008;118(1):84-95.